Pressure On Cholera Vaccine Stocks ‘Decreasing’: Gavi Alliance

  • 📰 channelstv
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 63%

Health Health Headlines News

A resurgence of cholera across Africa has driven an urgent need for more vaccine doses, but stock shortages have hampered the fight against the increasing outbreaks of the deadly disease.

But pressure on the supply of doses is now decreasing, said Aurelia Nguyen, chief programme officer of the Gavi vaccine alliance that raises funds to supply vaccines to developing countries.

“Due to the number of currently ongoing cholera outbreaks, our supply of vaccines was under pressure at the start of the year. But the pressure is now decreasing and we are once again in a position to immediately respond to new requests. “Cholera is part of the 10-year, $1 billion initiative aimed at supporting vaccine production in Africa.”“Climate change is a factor that is embedded in our new strategy. This is the first time that global warming has been a criteria for investment in future vaccinations — for example, against dengue fever.

“Gavi works closely with the WHO to keep an eye on new pathogens that may emerge, and we take climate shocks into account in our projections for future vaccine needs.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 7. in ERROR

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Cholera: FG shops for emergency vaccine dosesIn the wake of the cholera outbreak in the country, Nigeria has initiated discussions with the Global Alliance for Vaccines and Immunisation, Gavi, towards obtaining emergency supplies of the oral cholera vaccine (OCV) as the country battles the disease amid a global shortage of the vaccine.
Source: vanguardngrnews - 🏆 5. / 75 Read more »